The Prognostic Value of the Systemic Immune-Inflammation Index (SII) and Red Cell Distribution Width (RDW) in Patients with Cervical Cancer Treated Using Radiotherapy.
Emilia StaniewskaKarolina GrudzienMagdalena StankiewiczKatarzyna Raczek-ZwierzyckaJustyna Rembak-SzynkiewiczZuzanna NowickaRafal TarnawskiMarcin MiszczykPublished in: Cancers (2024)
The RDW is a cheap and widely available index that is simultaneously an independent prognostic factor for survival and could be used to improve pre-treatment prognosis assessments in patients with cervical cancer undergoing CRT. Available data encourage assessing the RDW as a prognostic factor in prospective trials to aid the identification of candidates for treatment escalation.
Keyphrases
- prognostic factors
- oxidative stress
- early stage
- single cell
- machine learning
- clinical trial
- radiation therapy
- randomized controlled trial
- heart failure
- squamous cell carcinoma
- big data
- cell therapy
- combination therapy
- open label
- locally advanced
- bone marrow
- replacement therapy
- smoking cessation
- bioinformatics analysis